Xtent Inc.

Menlo Park, CA • 650-475-9400 • www.xtentInc.com

Exchange and Ticker: XTNT: Nasdaq

Filing Range: 4.7M shares @ $16.00 to $18.00

Offering Price: $16.00

Close on First Day: $16.48

Offering Size: $75.20M

Shares Outstanding: 22,796,308

Underwriters: Piper Jaffray Cos.

Co-managers: SG Cowen Securities Corp/ Lazard Capital Markets/ RBC Capital Markets

Company Counsel: Wilson Sonsini Goodrich & Rosati

Manager Counsel: Latham & Watkins

Auditor: Pricewaterhouse Coopers LLP

Market Capitalization on 2/28/07: $333.97M

Close price at current month end: $14.65


Develops medical devices for stent delivery system for treatment of Coronary Artery Disease (CAD). The Company develops modular stent that can adjust length on a patient-by-patient basis for complex, longer blockages of the coronary artery requiring angioplasty. This adjustment can be made while the stent is being deployed in an occluded coronary artery. Competitors include Abbott Laboratories, Boston Scientific, Cook, Johnson & Johnson and Medtronic.


Adams Street Partners LLC; Advanced Technology Ventures (ATV); Latterell Venture Partners; Morgenthaler Ventures; St. Paul Venture Capital; Split Rock Partners

Source: Thomson Financial